Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium chloride 0.18%/glucose 4% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 10% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Dextrose 5g/100mL (5%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 25% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.9%/5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 150mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Infant dextrose 25% injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride+dextrose/saline 4%/0.18% 13.5mmol/500mL infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution and 2.5% dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 500 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.45%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 40% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 4% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.9%/glucose 5% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 5%/saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 70% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillin G + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 1000mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5% in 0.2% Normal Saline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.225%/5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+dextrose/saline infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+dextrose infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 250mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60% in water intravenous solution 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Dextrose 60% in water intravenous solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.45%/glucose 2.5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.18%/4% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 4% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.18%/10% infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Continuous infusion of dextrose saline |
Direct substance |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Milrinone lactate 200mcg/mL (5%) injection solution 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Compound sodium lactate infusion solution 500mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Compound sodium lactate infusion solution 1 L polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Continuous infusion of dextrose saline |
Direct substance |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glucose and glutathione and hypromellose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
240 minute plasma glucose measurement |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Continuous infusion of dextrose saline |
Direct substance |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ambulatory continuous glucose monitoring of interstitial tissue fluid with sensor placement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
300 minute plasma glucose measurement (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ambulatory continuous glucose monitoring of interstitial tissue fluid (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Measurement of glucose 4 hours after glucose challenge for glucose tolerance test |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of glucose 1 hour after glucose challenge for glucose tolerance test (procedure) |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of fasting glucose in urine specimen using dipstick |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine screening for glucose (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in first peritoneal dialysis fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose measurement by monitoring device (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in predialysis peritoneal dialysis fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of substance rate of glucose excretion in urine |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Calculation of estimated average glucose based on hemoglobin A1c |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
glucométrie en salle |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of urea, sodium, potassium, chloride, bicarbonate and glucose (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
4 |
Quantitative measurement of mass concentration of glucose in pericardial fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass rate of excretion of glucose in 24 hour urine specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of concentration of glucose in peritoneal dialysis fluid at 4 hours postperitoneal dialysis |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of glucose in serum or plasma specimen 6 hours after glucose challenge |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in postcalorie fasting serum or plasma specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in synovial fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in peritoneal dialysis fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in 1 hour postprandial urine specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in serum or plasma specimen 120 minutes after 75 gram oral glucose challenge (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Quantitative measurement of mass concentration of glucose in pleural fluid specimen (procedure) |
Component |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Tetracaine hydrochloride 0.2%/dextrose 6% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tetracaine hydrochloride 0.3%/dextrose 6% injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 7.5%ww/lidocaine hydrochloride 1.5%ww injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose tolerance test, antenatal |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of fasting glucose in urine specimen using dipstick |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Urine dipstick for glucose |
Component |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Protein-bound glucose (substance) |
Is a |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose- and sodium chloride-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose monohydrate (substance) |
Is a |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60% in water conventional release solution for infusion 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60% in water conventional release solution for infusion 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Protein-bound glucose (substance) |
Is modification of (attribute) |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose monohydrate (substance) |
Is modification of (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Anhydrous glucose |
Is modification of (attribute) |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose- and potassium chloride-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glucose and potassium chloride and sodium chloride in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bupivacaine and glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Caffeine and glucose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose and glutathione and hypromellose only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Glucose and treacle only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Glucose and potassium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glucose and potassium chloride and sodium chloride only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glucose |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |